Selenium deficiency in celiac disease: Risk of autoimmune thyroid diseases;Carenza di selenio nella malattia celiaca: Rischio di tireopatie autoimmuni

Minerva Medica

Volumn 99, Issue 6, 2008, Pages 643-653

  Stazi, A V ^a   Trinti, B ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Apoptosis; Autoimmune ; Celiac disease ; Dinase type iii ; Glutathione peroxidase ; Interleukin 15 ; Iodothyronine deio ; Selenium ; Thioredoxin reductases ; Thyroiditis

Indexed keywords

INTERLEUKIN 15;

APOPTOSIS; CELIAC DISEASE; CELL PROLIFERATION; CYTOTOXICITY; GENE EXPRESSION; HUMAN; MALABSORPTION; PROTEIN EXPRESSION; REVIEW; SELENIUM DEFICIENCY; TH1 CELL; THYROID DISEASE;

APOPTOSIS; CELIAC DISEASE; GLUTATHIONE PEROXIDASE; HASHIMOTO DISEASE; HUMANS; INTERLEUKIN-15; IODIDE PEROXIDASE; SELENIUM; SELENOPROTEINS; THIOREDOXIN-DISULFIDE REDUCTASE;

EID: 59649099491     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Finley JW. Bioavailability of selenium from food. Nutr Rev 2006;64:143-51.
2. Rayman MP. The importance of selenium to human health. Lacet 2000;356:233-41.
3. EFSA (European Food Safety Authority). Tolerable upper intake levels for vitamins and minerals. Ed. Febbraio 2006.
4. Fang W, Wu P, Hu R, Huang Z. Environmental Se-Mo-B deficiency and its possible effects on crops and Keshan-Beck disease (KBD) in the Chousang area, Yao County, Shaanxi Province, China. Environ Geochem Health 2003;25:267-80.
5. Spadaccino AC, Basso D, Chiarelli S, Albergoni MP, D'Odorico A, Plebani M et al. Celiac disease in North Italian patients with autoimmune thyroid diseases. Autoimmunity 2008;41:116-21.
6. Iuorio R, Mercuri V, Barbarulo F, D'Amico T, Mecca N, Bassotti G et al. Prevalence of celiac disease in patients with autoimmune thyroiditis. Minerva Endocrinol 2007;32:239-43.
7. L.A.R.N. Ed. 2005.
8. Daniels LA. Selenium: does selenium status have health outcomes beyond overt deficiency? Med J Aust 2004;180:373-4.
9. Basu TK, Donaldson D. Intestinal absorption in health and disease: micronutrients. Best Pract Res Clin Gastroenterol 2003;17:957-79.
10. Kohrle J, Jacob B, Contemprè B, DumontJE. Selenium, the thyroid, and the endocrine system. Endocr Rev 2005;26:944-84.
11. Schweizer U, Streckfuss F, Pelt P, Hatfield DL, Kohrle J, Schomburg L. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem J 2005;386:221-6.
12. Rayman MP. The importance of selenium to human health. Lancet 2000;356:233-41.
13. Pagmantidis V, Bermano G, Villette S, Broom I, Arthur J, Hesketh J. Effects of Se-depletion on glutathione peroxidase and selenoprotein W gene expretion in thebcolon. FEBS Lett 2005;579:792-6.
14. Marcus RW. Myopathy and cardiomyopathy associated with selenium deficincy: case report, literature review and hypothesis. Md Me J 1993,42:669-74.
15. Monte M, Sacerdote de Lustig E. Free radicals of oxygen and superoxide dismutase. Biological and medical aspect. Medicina (B Airres) 1994;54:61-8.
16. Wojtczak A. Selenium as an anticancerogenic agent. Acta Pol Pharma 2003;60:215-7.
17. Olmez A Yalcin S, Yurdakok K, Coskun T. Serum selenium levels in acute gastroenteritis of possible viral origin. Trop Pediatr 2004;50:78-81.
18. Biaglow JE, Miller RA. The thioredoxin reductase/thiore-doxin system: novel redox targes for cancer therapy. Cancer Biol Ther 2005;4:6-13.
19. Gallegos A, Berggren M, Gasdaska JR, Powis G. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res 1997;57:4965-70.
20. Berggren MM, ManginJF, Gasdaka JR, Powis G. Effect of selenium on rat thioredoxin reductase activity: increase by supranutritional selenium and decrease by selenium deficiency. Biochem Pharmacol 1999:57:187-93.
21. Mustacich D, Powis G. Thioredoxin reductese. Biochem J 2000;346 Pt 1:1-8.
22. Rayman MP, Thompson AJ, Bekaert B, Catterick J, Galassini R, Hall E et al. Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am J Clin Nutr 2008;87:370-8.
23. Corazza GR, Biagi F, Ciccocioppo R, Di Sabatino A. La malattia celiaca. Medicina Italia 2007;1:4-6.
24. van Heel DA. Interleukin 15: its role in intestinal inflammation. Gut 2006;55:444-5.
25. Di Sabatino A, Ciccocioppo R, Cupelli F, Cinque B, Millimaggi D, Clarkson MM et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006;55:469-77.
26. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000;191:771-80.
27. Lee DH, Esworthy RS, Chu C, Pfeifer GP, Chu FF. Mutation accumulation in the intestine and colon of mice deficient in two intracellular glutathione peroxidases. Cancer Res 2006;66:9845-51.
28. Bartel J, Bartz T, Wolf C, Charkiewicz E, Kuhbacher M, Pohl T et al. Activity of the glutathione peroxidase - 2. Differences in the selenium-dependent expression between colon and small intestine. Cancer Genomics Proteomics 2007;4:369-72.
29. Ajjan RA, Watson PF, Weetman AP. Detection of IL-12, IL-13 and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1997;82:666-9.
30. Choi EW, Shin IS, Bhang DH, Lee DH, Bae BK, Kang MS et al. Hormonal change and cytokine mRNA expression in peripheral blood mononuclear cells during the development of canine autoimmune thyroiditis. Clin Exp Immunol 2006;146:101-8.
31. Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M. Thl and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Thl) and Graves' disease (Th2). Neuroimmunomodulation 2004; 11:209-13
32. Poncin S, Lengelé B, Colin IM, Gérard AC. Differential interactions between Thl/Th2, Thl/Th3, and Th2/Th3 cytokines in the regulation of thyroperoxidase and dual oxidase expression, and of thyroglobulin secretion in thyrocytes in vitro. Endocrinology 2008:149:1534-42.
33. Suzuki A, McCall S, Choi SS, Sicklick JK, Huang J, Qi Y et al. Interleukin-15 increases hepatic regenerative activity. J Hepatol 2006;45:410-8.
34. Gartner R, Gasnier BC, Dietrich JW, Krebs B, Angstwunn MW. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002:87:1687-91.
35. Ban Y, Tomer Y. Genetic susceptibility in thyroid autoimmunity. Pediatr Endocrinol Rev 2005;3:20-32.
36. Ch'ng CL, Jones MK, Kingham JG. Celiac disease and autoimmune thyroid disease. Clin Med Res 2007;5:184-92
37. Schmutzler C, Mentrup B, Schomburg L, Hoang-Vu C, Herzog V, Kohrle J. Selenoproteins of the thyroid gland: espression, localization and possibile function of clutathione peroxidase 3. Biol Chem 2007:388:1053-9.
38. Kohrle J. Selenium and the control of thyroid hormone metabolism. Thyroid 2005;15:841-53.
39. Dahele A. Ghosh S. Vitamin B12 deficiency in untreated celiac disease. Am J Gastroenerol 2001;96:745-50.
40. Stazi AV. Trinti B. Aspetti riproduttivi della malattia celiaca. Ann Ital Med Int 2005;20:143-57.
41. Stazi AV, Trinti B. Reproduction, endocrine disorders and celiac disease: risk factors of osteoporosis. Minerva Med 2006;97;191-203.
42. Jurasovic J. Cvitkovic P, Pizent A, Colak B, Telisman S. Semen quality and reproductive endocrine function with regard to blood cadmium in Croatian male subjects. Biometals 2004;17:735-43.
43. Cortigiani L, Nutini P, Caiulo VA, Ughi C, Ceccarelli M. Selenium in celiac disease. Minerva Pediatr 1989:41:539-42.
44. Kalita B, Nowak P, Slimok M, Sikora A, Szkilnik R, Obuchowicz A et al. Selenium plasma concentrations in children with celiac disease in different stages of diagnosis. Pol Merkur Lekarski 2002;12:43-4.
45. Frolova B, Manerov FK, Gmoshinskii IV, Mazo VK, Zorin SN. Selenium safety in children with protracted diarrhea syndrome. Vopr Pitan 2004;73:32-5.
46. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid 2007 17:609-12.
47. Karanikas G, Schuetz M, Kontur S, Duan H, Kommata S, Schoen R et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid 2008;18:7-12.
48. Wertenbruch T, Willenberg HS, Sagert C, Nguyen TB, Bahlo M, Feldkamp J et al. Serum selenium levels in patients with remission and relapse of graves' disease. Med Chem 2007;3:281-4.